7.1799
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Research and Development |
24.85%
5.814
|
7.737 | - | - | - |
Operating Income/Loss |
37.21%
-10.33
|
-16.46 | -14.27 | -20.70 | -17.38 |
Income/Loss From Continuing Operations Before Tax |
39.08%
-9.385
|
-15.40 | -12.72 | -19.34 | -15.99 |
Income/Loss From Continuing Operations After Tax |
39.08%
-9.385
|
-15.40 | -12.72 | -19.34 | -15.99 |
|
39.08%
-9.385
|
-15.40 | -12.72 | -19.34 | -15.99 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
94.90%
3.1689
|
62.11 | 0.4845 | 61.76 | 61.68 |
Diluted Average Shares |
94.90%
3.1689
|
62.11 | 0.4845 | 61.76 | 61.68 |
Basic Earnings Per Share |
1,084%
-2.96
|
-0.25 | -0.20 | -0.31 | -0.26 |
Diluted Earnings Per Share |
1,084%
-2.96
|
-0.25 | -0.20 | -0.31 | -0.26 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):